A PACS Admin’s Life

One man takes on the world of PACS, RIS, dicom, and all that is digital imaging.

Hormone therapy before brachytherapy increases mortality in older patients

BOSTON—Men over 70 years of age with early-stage prostate cancer have
20 percent higher mortality if they are treated with hormone therapy
before being treated with brachytherapy, compared to men who are
treated with brachytherapy alone, according to a large cohort study
presented Tuesday at the 50th annual meeting of the American Society
for Therapeutic Radiology and Oncology (ASTRO).

Bookmark to:
Add 'Hormone therapy before brachytherapy increases mortality in older patients' to Del.icio.us Add 'Hormone therapy before brachytherapy increases mortality in older patients' to digg Add 'Hormone therapy before brachytherapy increases mortality in older patients' to FURL Add 'Hormone therapy before brachytherapy increases mortality in older patients' to blinklist Add 'Hormone therapy before brachytherapy increases mortality in older patients' to My-Tuts Add 'Hormone therapy before brachytherapy increases mortality in older patients' to reddit Add 'Hormone therapy before brachytherapy increases mortality in older patients' to Feed Me Links! Add 'Hormone therapy before brachytherapy increases mortality in older patients' to Technorati Add 'Hormone therapy before brachytherapy increases mortality in older patients' to Socializer 

Syndicate

Sponsership Centre

Activity

No comments, leave your comment or trackback.

Leave a Reply


Search

The archives run deep. Feel free to search older content using topic keywords.

  You're new! If you like it here, please subscribe to my feed.      
[Close]